0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cerebrovascular Intervention Guidewire Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-12T18025
Home | Market Reports | Health| Medical Devices & Equipment
Global Cerebrovascular Intervention Guidewire Market Research Report 2024
BUY CHAPTERS

Global Cerebrovascular Intervention Guidewire Market Research Report 2026

Code: QYRE-Auto-12T18025
Report
2026-02-11
Pages:148
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cerebrovascular Intervention Guidewire Market

The global Cerebrovascular Intervention Guidewire market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cerebrovascular Intervention Guidewire competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cerebrovascular Intervention Guidewires are thin, flexible wire used in neurointerventional procedures to access and navigate through blood vessels in the brain and spinal cord. The wire is inserted through a catheter and carefully guided to the target site, serving as a pathway for placing other devices such as stents or coils.
The North American market for Cerebrovascular Intervention Guidewire is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cerebrovascular Intervention Guidewire is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Cerebrovascular Intervention Guidewire include Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation, B. Braun Melsungen, Teleflex, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cerebrovascular Intervention Guidewire market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cerebrovascular Intervention Guidewire. The Cerebrovascular Intervention Guidewire market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cerebrovascular Intervention Guidewire market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cerebrovascular Intervention Guidewire manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cerebrovascular Intervention Guidewire Market Report

Report Metric Details
Report Name Cerebrovascular Intervention Guidewire Market
Segment by Type
  • Stainless Steel Type
  • Alloy Type
  • Others
by Application
  • Hospitals
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation, B. Braun Melsungen, Teleflex, TE Con​​nectivity, Johnson & Johnson, Smiths Group, Asahi Intecc, Cordis Corporation, Cook Medical, Lepu Meidcal, Scientia Vascular, FMD Co., Ltd., Sino Medical Sciences Technology Inc., MicroPort NeuroTech, Shanghai HeartCare Medical Technology Corporation Limited, Peijia Medical, Zhejiang Medical Devices Co., Ltd. Owned By Year, Shanghai Yingtai Medical Equipment, Beijing Taijieweiye Technology, Shunmei MEDICAL, MicroVenti, Artiria Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Cerebrovascular Intervention Guidewire manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Cerebrovascular Intervention Guidewire sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Cerebrovascular Intervention Guidewire Market report?

Ans: The main players in the Cerebrovascular Intervention Guidewire Market are Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation, B. Braun Melsungen, Teleflex, TE Con​​nectivity, Johnson & Johnson, Smiths Group, Asahi Intecc, Cordis Corporation, Cook Medical, Lepu Meidcal, Scientia Vascular, FMD Co., Ltd., Sino Medical Sciences Technology Inc., MicroPort NeuroTech, Shanghai HeartCare Medical Technology Corporation Limited, Peijia Medical, Zhejiang Medical Devices Co., Ltd. Owned By Year, Shanghai Yingtai Medical Equipment, Beijing Taijieweiye Technology, Shunmei MEDICAL, MicroVenti, Artiria Medical

What are the Application segmentation covered in the Cerebrovascular Intervention Guidewire Market report?

Ans: The Applications covered in the Cerebrovascular Intervention Guidewire Market report are Hospitals, Clinic, Other

What are the Type segmentation covered in the Cerebrovascular Intervention Guidewire Market report?

Ans: The Types covered in the Cerebrovascular Intervention Guidewire Market report are Stainless Steel Type, Alloy Type, Others

1 Cerebrovascular Intervention Guidewire Market Overview
1.1 Product Definition
1.2 Cerebrovascular Intervention Guidewire by Type
1.2.1 Global Cerebrovascular Intervention Guidewire Market Value by Type: 2025 vs 2032
1.2.2 Stainless Steel Type
1.2.3 Alloy Type
1.2.4 Others
1.3 Cerebrovascular Intervention Guidewire by Application
1.3.1 Global Cerebrovascular Intervention Guidewire Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Global Cerebrovascular Intervention Guidewire Market Size Estimates and Forecasts
1.4.1 Global Cerebrovascular Intervention Guidewire Revenue 2021–2032
1.4.2 Global Cerebrovascular Intervention Guidewire Sales 2021–2032
1.4.3 Global Cerebrovascular Intervention Guidewire Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cerebrovascular Intervention Guidewire Market Competition by Manufacturers
2.1 Global Cerebrovascular Intervention Guidewire Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cerebrovascular Intervention Guidewire Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cerebrovascular Intervention Guidewire Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cerebrovascular Intervention Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cerebrovascular Intervention Guidewire, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cerebrovascular Intervention Guidewire, Product Types and Applications
2.7 Global Key Manufacturers of Cerebrovascular Intervention Guidewire, Date of Entry into the Industry
2.8 Global Cerebrovascular Intervention Guidewire Market Competitive Situation and Trends
2.8.1 Global Cerebrovascular Intervention Guidewire Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cerebrovascular Intervention Guidewire Players Market Share by Revenue
2.8.3 Global Cerebrovascular Intervention Guidewire Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cerebrovascular Intervention Guidewire Market Scenario by Region
3.1 Global Cerebrovascular Intervention Guidewire Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cerebrovascular Intervention Guidewire Sales by Region: 2021–2032
3.2.1 Global Cerebrovascular Intervention Guidewire Sales by Region: 2021–2026
3.2.2 Global Cerebrovascular Intervention Guidewire Sales by Region: 2027–2032
3.3 Global Cerebrovascular Intervention Guidewire Revenue by Region: 2021–2032
3.3.1 Global Cerebrovascular Intervention Guidewire Revenue by Region: 2021–2026
3.3.2 Global Cerebrovascular Intervention Guidewire Revenue by Region: 2027–2032
3.4 North America Cerebrovascular Intervention Guidewire Market Facts & Figures by Country
3.4.1 North America Cerebrovascular Intervention Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cerebrovascular Intervention Guidewire Sales by Country (2021–2032)
3.4.3 North America Cerebrovascular Intervention Guidewire Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cerebrovascular Intervention Guidewire Market Facts & Figures by Country
3.5.1 Europe Cerebrovascular Intervention Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cerebrovascular Intervention Guidewire Sales by Country (2021–2032)
3.5.3 Europe Cerebrovascular Intervention Guidewire Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cerebrovascular Intervention Guidewire Market Facts & Figures by Region
3.6.1 Asia Pacific Cerebrovascular Intervention Guidewire Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cerebrovascular Intervention Guidewire Sales by Region (2021–2032)
3.6.3 Asia Pacific Cerebrovascular Intervention Guidewire Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cerebrovascular Intervention Guidewire Market Facts & Figures by Country
3.7.1 Latin America Cerebrovascular Intervention Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cerebrovascular Intervention Guidewire Sales by Country (2021–2032)
3.7.3 Latin America Cerebrovascular Intervention Guidewire Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cerebrovascular Intervention Guidewire Market Facts & Figures by Country
3.8.1 Middle East and Africa Cerebrovascular Intervention Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cerebrovascular Intervention Guidewire Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cerebrovascular Intervention Guidewire Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cerebrovascular Intervention Guidewire Sales by Type (2021–2032)
4.1.1 Global Cerebrovascular Intervention Guidewire Sales by Type (2021–2026)
4.1.2 Global Cerebrovascular Intervention Guidewire Sales by Type (2027–2032)
4.1.3 Global Cerebrovascular Intervention Guidewire Sales Market Share by Type (2021–2032)
4.2 Global Cerebrovascular Intervention Guidewire Revenue by Type (2021–2032)
4.2.1 Global Cerebrovascular Intervention Guidewire Revenue by Type (2021–2026)
4.2.2 Global Cerebrovascular Intervention Guidewire Revenue by Type (2027–2032)
4.2.3 Global Cerebrovascular Intervention Guidewire Revenue Market Share by Type (2021–2032)
4.3 Global Cerebrovascular Intervention Guidewire Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cerebrovascular Intervention Guidewire Sales by Application (2021–2032)
5.1.1 Global Cerebrovascular Intervention Guidewire Sales by Application (2021–2026)
5.1.2 Global Cerebrovascular Intervention Guidewire Sales by Application (2027–2032)
5.1.3 Global Cerebrovascular Intervention Guidewire Sales Market Share by Application (2021–2032)
5.2 Global Cerebrovascular Intervention Guidewire Revenue by Application (2021–2032)
5.2.1 Global Cerebrovascular Intervention Guidewire Revenue by Application (2021–2026)
5.2.2 Global Cerebrovascular Intervention Guidewire Revenue by Application (2027–2032)
5.2.3 Global Cerebrovascular Intervention Guidewire Revenue Market Share by Application (2021–2032)
5.3 Global Cerebrovascular Intervention Guidewire Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Terumo Medical
6.1.1 Terumo Medical Company Information
6.1.2 Terumo Medical Description and Business Overview
6.1.3 Terumo Medical Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Terumo Medical Cerebrovascular Intervention Guidewire Product Portfolio
6.1.5 Terumo Medical Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Medtronic Cerebrovascular Intervention Guidewire Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abbott Laboratories Cerebrovascular Intervention Guidewire Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Company Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Stryker Cerebrovascular Intervention Guidewire Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 Penumbra
6.5.1 Penumbra Company Information
6.5.2 Penumbra Description and Business Overview
6.5.3 Penumbra Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Penumbra Cerebrovascular Intervention Guidewire Product Portfolio
6.5.5 Penumbra Recent Developments/Updates
6.6 Merit Medical Systems
6.6.1 Merit Medical Systems Company Information
6.6.2 Merit Medical Systems Description and Business Overview
6.6.3 Merit Medical Systems Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Merit Medical Systems Cerebrovascular Intervention Guidewire Product Portfolio
6.6.5 Merit Medical Systems Recent Developments/Updates
6.7 Boston Scientific
6.7.1 Boston Scientific Company Information
6.7.2 Boston Scientific Description and Business Overview
6.7.3 Boston Scientific Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Boston Scientific Cerebrovascular Intervention Guidewire Product Portfolio
6.7.5 Boston Scientific Recent Developments/Updates
6.8 Integer Holdings Corporation
6.8.1 Integer Holdings Corporation Company Information
6.8.2 Integer Holdings Corporation Description and Business Overview
6.8.3 Integer Holdings Corporation Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Integer Holdings Corporation Cerebrovascular Intervention Guidewire Product Portfolio
6.8.5 Integer Holdings Corporation Recent Developments/Updates
6.9 B. Braun Melsungen
6.9.1 B. Braun Melsungen Company Information
6.9.2 B. Braun Melsungen Description and Business Overview
6.9.3 B. Braun Melsungen Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 B. Braun Melsungen Cerebrovascular Intervention Guidewire Product Portfolio
6.9.5 B. Braun Melsungen Recent Developments/Updates
6.10 Teleflex
6.10.1 Teleflex Company Information
6.10.2 Teleflex Description and Business Overview
6.10.3 Teleflex Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Teleflex Cerebrovascular Intervention Guidewire Product Portfolio
6.10.5 Teleflex Recent Developments/Updates
6.11 TE Con​​nectivity
6.11.1 TE Con​​nectivity Company Information
6.11.2 TE Con​​nectivity Description and Business Overview
6.11.3 TE Con​​nectivity Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 TE Con​​nectivity Cerebrovascular Intervention Guidewire Product Portfolio
6.11.5 TE Con​​nectivity Recent Developments/Updates
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Company Information
6.12.2 Johnson & Johnson Description and Business Overview
6.12.3 Johnson & Johnson Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Johnson & Johnson Cerebrovascular Intervention Guidewire Product Portfolio
6.12.5 Johnson & Johnson Recent Developments/Updates
6.13 Smiths Group
6.13.1 Smiths Group Company Information
6.13.2 Smiths Group Description and Business Overview
6.13.3 Smiths Group Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Smiths Group Cerebrovascular Intervention Guidewire Product Portfolio
6.13.5 Smiths Group Recent Developments/Updates
6.14 Asahi Intecc
6.14.1 Asahi Intecc Company Information
6.14.2 Asahi Intecc Description and Business Overview
6.14.3 Asahi Intecc Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Asahi Intecc Cerebrovascular Intervention Guidewire Product Portfolio
6.14.5 Asahi Intecc Recent Developments/Updates
6.15 Cordis Corporation
6.15.1 Cordis Corporation Company Information
6.15.2 Cordis Corporation Description and Business Overview
6.15.3 Cordis Corporation Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Cordis Corporation Cerebrovascular Intervention Guidewire Product Portfolio
6.15.5 Cordis Corporation Recent Developments/Updates
6.16 Cook Medical
6.16.1 Cook Medical Company Information
6.16.2 Cook Medical Description and Business Overview
6.16.3 Cook Medical Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Cook Medical Cerebrovascular Intervention Guidewire Product Portfolio
6.16.5 Cook Medical Recent Developments/Updates
6.17 Lepu Meidcal
6.17.1 Lepu Meidcal Company Information
6.17.2 Lepu Meidcal Description and Business Overview
6.17.3 Lepu Meidcal Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Lepu Meidcal Cerebrovascular Intervention Guidewire Product Portfolio
6.17.5 Lepu Meidcal Recent Developments/Updates
6.18 Scientia Vascular
6.18.1 Scientia Vascular Company Information
6.18.2 Scientia Vascular Description and Business Overview
6.18.3 Scientia Vascular Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Scientia Vascular Cerebrovascular Intervention Guidewire Product Portfolio
6.18.5 Scientia Vascular Recent Developments/Updates
6.19 FMD Co., Ltd.
6.19.1 FMD Co., Ltd. Company Information
6.19.2 FMD Co., Ltd. Description and Business Overview
6.19.3 FMD Co., Ltd. Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 FMD Co., Ltd. Cerebrovascular Intervention Guidewire Product Portfolio
6.19.5 FMD Co., Ltd. Recent Developments/Updates
6.20 Sino Medical Sciences Technology Inc.
6.20.1 Sino Medical Sciences Technology Inc. Company Information
6.20.2 Sino Medical Sciences Technology Inc. Description and Business Overview
6.20.3 Sino Medical Sciences Technology Inc. Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Sino Medical Sciences Technology Inc. Cerebrovascular Intervention Guidewire Product Portfolio
6.20.5 Sino Medical Sciences Technology Inc. Recent Developments/Updates
6.21 MicroPort NeuroTech
6.21.1 MicroPort NeuroTech Company Information
6.21.2 MicroPort NeuroTech Description and Business Overview
6.21.3 MicroPort NeuroTech Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 MicroPort NeuroTech Cerebrovascular Intervention Guidewire Product Portfolio
6.21.5 MicroPort NeuroTech Recent Developments/Updates
6.22 Shanghai HeartCare Medical Technology Corporation Limited
6.22.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
6.22.2 Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
6.22.3 Shanghai HeartCare Medical Technology Corporation Limited Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Shanghai HeartCare Medical Technology Corporation Limited Cerebrovascular Intervention Guidewire Product Portfolio
6.22.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
6.23 Peijia Medical
6.23.1 Peijia Medical Company Information
6.23.2 Peijia Medical Description and Business Overview
6.23.3 Peijia Medical Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Peijia Medical Cerebrovascular Intervention Guidewire Product Portfolio
6.23.5 Peijia Medical Recent Developments/Updates
6.24 Zhejiang Medical Devices Co., Ltd. Owned By Year
6.24.1 Zhejiang Medical Devices Co., Ltd. Owned By Year Company Information
6.24.2 Zhejiang Medical Devices Co., Ltd. Owned By Year Description and Business Overview
6.24.3 Zhejiang Medical Devices Co., Ltd. Owned By Year Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Zhejiang Medical Devices Co., Ltd. Owned By Year Cerebrovascular Intervention Guidewire Product Portfolio
6.24.5 Zhejiang Medical Devices Co., Ltd. Owned By Year Recent Developments/Updates
6.25 Shanghai Yingtai Medical Equipment
6.25.1 Shanghai Yingtai Medical Equipment Company Information
6.25.2 Shanghai Yingtai Medical Equipment Description and Business Overview
6.25.3 Shanghai Yingtai Medical Equipment Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Shanghai Yingtai Medical Equipment Cerebrovascular Intervention Guidewire Product Portfolio
6.25.5 Shanghai Yingtai Medical Equipment Recent Developments/Updates
6.26 Beijing Taijieweiye Technology
6.26.1 Beijing Taijieweiye Technology Company Information
6.26.2 Beijing Taijieweiye Technology Description and Business Overview
6.26.3 Beijing Taijieweiye Technology Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Beijing Taijieweiye Technology Cerebrovascular Intervention Guidewire Product Portfolio
6.26.5 Beijing Taijieweiye Technology Recent Developments/Updates
6.27 Shunmei MEDICAL
6.27.1 Shunmei MEDICAL Company Information
6.27.2 Shunmei MEDICAL Description and Business Overview
6.27.3 Shunmei MEDICAL Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 Shunmei MEDICAL Cerebrovascular Intervention Guidewire Product Portfolio
6.27.5 Shunmei MEDICAL Recent Developments/Updates
6.28 MicroVenti
6.28.1 MicroVenti Company Information
6.28.2 MicroVenti Description and Business Overview
6.28.3 MicroVenti Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 MicroVenti Cerebrovascular Intervention Guidewire Product Portfolio
6.28.5 MicroVenti Recent Developments/Updates
6.29 Artiria Medical
6.29.1 Artiria Medical Company Information
6.29.2 Artiria Medical Description and Business Overview
6.29.3 Artiria Medical Cerebrovascular Intervention Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Artiria Medical Cerebrovascular Intervention Guidewire Product Portfolio
6.29.5 Artiria Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cerebrovascular Intervention Guidewire Industry Chain Analysis
7.2 Cerebrovascular Intervention Guidewire Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cerebrovascular Intervention Guidewire Production Mode & Process Analysis
7.4 Cerebrovascular Intervention Guidewire Sales and Marketing
7.4.1 Cerebrovascular Intervention Guidewire Sales Channels
7.4.2 Cerebrovascular Intervention Guidewire Distributors
7.5 Cerebrovascular Intervention Guidewire Customer Analysis
8 Cerebrovascular Intervention Guidewire Market Dynamics
8.1 Cerebrovascular Intervention Guidewire Industry Trends
8.2 Cerebrovascular Intervention Guidewire Market Drivers
8.3 Cerebrovascular Intervention Guidewire Market Challenges
8.4 Cerebrovascular Intervention Guidewire Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cerebrovascular Intervention Guidewire Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Cerebrovascular Intervention Guidewire Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Cerebrovascular Intervention Guidewire Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Cerebrovascular Intervention Guidewire Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Cerebrovascular Intervention Guidewire Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Cerebrovascular Intervention Guidewire Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Cerebrovascular Intervention Guidewire Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Cerebrovascular Intervention Guidewire Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Cerebrovascular Intervention Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Cerebrovascular Intervention Guidewire, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Cerebrovascular Intervention Guidewire, Product Types and Applications
 Table 12. Global Key Manufacturers of Cerebrovascular Intervention Guidewire, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cerebrovascular Intervention Guidewire Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cerebrovascular Intervention Guidewire Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cerebrovascular Intervention Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Cerebrovascular Intervention Guidewire Sales by Region (K Units), 2021–2026
 Table 18. Global Cerebrovascular Intervention Guidewire Sales Market Share by Region (2021–2026)
 Table 19. Global Cerebrovascular Intervention Guidewire Sales by Region (K Units), 2027–2032
 Table 20. Global Cerebrovascular Intervention Guidewire Sales Market Share by Region (2027–2032)
 Table 21. Global Cerebrovascular Intervention Guidewire Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Cerebrovascular Intervention Guidewire Revenue Market Share by Region (2021–2026)
 Table 23. Global Cerebrovascular Intervention Guidewire Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Cerebrovascular Intervention Guidewire Revenue Market Share by Region (2027–2032)
 Table 25. North America Cerebrovascular Intervention Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Cerebrovascular Intervention Guidewire Sales by Country (K Units), 2021–2026
 Table 27. North America Cerebrovascular Intervention Guidewire Sales by Country (K Units), 2027–2032
 Table 28. North America Cerebrovascular Intervention Guidewire Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Cerebrovascular Intervention Guidewire Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Cerebrovascular Intervention Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Cerebrovascular Intervention Guidewire Sales by Country (K Units), 2021–2026
 Table 32. Europe Cerebrovascular Intervention Guidewire Sales by Country (K Units), 2027–2032
 Table 33. Europe Cerebrovascular Intervention Guidewire Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Cerebrovascular Intervention Guidewire Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Cerebrovascular Intervention Guidewire Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Cerebrovascular Intervention Guidewire Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Cerebrovascular Intervention Guidewire Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Cerebrovascular Intervention Guidewire Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Cerebrovascular Intervention Guidewire Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Cerebrovascular Intervention Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Cerebrovascular Intervention Guidewire Sales by Country (K Units), 2021–2026
 Table 42. Latin America Cerebrovascular Intervention Guidewire Sales by Country (K Units), 2027–2032
 Table 43. Latin America Cerebrovascular Intervention Guidewire Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Cerebrovascular Intervention Guidewire Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Cerebrovascular Intervention Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Cerebrovascular Intervention Guidewire Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Cerebrovascular Intervention Guidewire Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Cerebrovascular Intervention Guidewire Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Cerebrovascular Intervention Guidewire Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Cerebrovascular Intervention Guidewire Sales (K Units) by Type (2021–2026)
 Table 51. Global Cerebrovascular Intervention Guidewire Sales (K Units) by Type (2027–2032)
 Table 52. Global Cerebrovascular Intervention Guidewire Sales Market Share by Type (2021–2026)
 Table 53. Global Cerebrovascular Intervention Guidewire Sales Market Share by Type (2027–2032)
 Table 54. Global Cerebrovascular Intervention Guidewire Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Cerebrovascular Intervention Guidewire Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Cerebrovascular Intervention Guidewire Revenue Market Share by Type (2021–2026)
 Table 57. Global Cerebrovascular Intervention Guidewire Revenue Market Share by Type (2027–2032)
 Table 58. Global Cerebrovascular Intervention Guidewire Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Cerebrovascular Intervention Guidewire Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Cerebrovascular Intervention Guidewire Sales (K Units) by Application (2021–2026)
 Table 61. Global Cerebrovascular Intervention Guidewire Sales (K Units) by Application (2027–2032)
 Table 62. Global Cerebrovascular Intervention Guidewire Sales Market Share by Application (2021–2026)
 Table 63. Global Cerebrovascular Intervention Guidewire Sales Market Share by Application (2027–2032)
 Table 64. Global Cerebrovascular Intervention Guidewire Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Cerebrovascular Intervention Guidewire Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Cerebrovascular Intervention Guidewire Revenue Market Share by Application (2021–2026)
 Table 67. Global Cerebrovascular Intervention Guidewire Revenue Market Share by Application (2027–2032)
 Table 68. Global Cerebrovascular Intervention Guidewire Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Cerebrovascular Intervention Guidewire Price (US$/Unit) by Application (2027–2032)
 Table 70. Terumo Medical Company Information
 Table 71. Terumo Medical Description and Business Overview
 Table 72. Terumo Medical Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Terumo Medical Cerebrovascular Intervention Guidewire Product
 Table 74. Terumo Medical Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Medtronic Cerebrovascular Intervention Guidewire Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. Abbott Laboratories Company Information
 Table 81. Abbott Laboratories Description and Business Overview
 Table 82. Abbott Laboratories Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Abbott Laboratories Cerebrovascular Intervention Guidewire Product
 Table 84. Abbott Laboratories Recent Developments/Updates
 Table 85. Stryker Company Information
 Table 86. Stryker Description and Business Overview
 Table 87. Stryker Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Stryker Cerebrovascular Intervention Guidewire Product
 Table 89. Stryker Recent Developments/Updates
 Table 90. Penumbra Company Information
 Table 91. Penumbra Description and Business Overview
 Table 92. Penumbra Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Penumbra Cerebrovascular Intervention Guidewire Product
 Table 94. Penumbra Recent Developments/Updates
 Table 95. Merit Medical Systems Company Information
 Table 96. Merit Medical Systems Description and Business Overview
 Table 97. Merit Medical Systems Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Merit Medical Systems Cerebrovascular Intervention Guidewire Product
 Table 99. Merit Medical Systems Recent Developments/Updates
 Table 100. Boston Scientific Company Information
 Table 101. Boston Scientific Description and Business Overview
 Table 102. Boston Scientific Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Boston Scientific Cerebrovascular Intervention Guidewire Product
 Table 104. Boston Scientific Recent Developments/Updates
 Table 105. Integer Holdings Corporation Company Information
 Table 106. Integer Holdings Corporation Description and Business Overview
 Table 107. Integer Holdings Corporation Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Integer Holdings Corporation Cerebrovascular Intervention Guidewire Product
 Table 109. Integer Holdings Corporation Recent Developments/Updates
 Table 110. B. Braun Melsungen Company Information
 Table 111. B. Braun Melsungen Description and Business Overview
 Table 112. B. Braun Melsungen Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. B. Braun Melsungen Cerebrovascular Intervention Guidewire Product
 Table 114. B. Braun Melsungen Recent Developments/Updates
 Table 115. Teleflex Company Information
 Table 116. Teleflex Description and Business Overview
 Table 117. Teleflex Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Teleflex Cerebrovascular Intervention Guidewire Product
 Table 119. Teleflex Recent Developments/Updates
 Table 120. TE Con​​nectivity Company Information
 Table 121. TE Con​​nectivity Description and Business Overview
 Table 122. TE Con​​nectivity Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. TE Con​​nectivity Cerebrovascular Intervention Guidewire Product
 Table 124. TE Con​​nectivity Recent Developments/Updates
 Table 125. Johnson & Johnson Company Information
 Table 126. Johnson & Johnson Description and Business Overview
 Table 127. Johnson & Johnson Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Johnson & Johnson Cerebrovascular Intervention Guidewire Product
 Table 129. Johnson & Johnson Recent Developments/Updates
 Table 130. Smiths Group Company Information
 Table 131. Smiths Group Description and Business Overview
 Table 132. Smiths Group Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Smiths Group Cerebrovascular Intervention Guidewire Product
 Table 134. Smiths Group Recent Developments/Updates
 Table 135. Asahi Intecc Company Information
 Table 136. Asahi Intecc Description and Business Overview
 Table 137. Asahi Intecc Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Asahi Intecc Cerebrovascular Intervention Guidewire Product
 Table 139. Asahi Intecc Recent Developments/Updates
 Table 140. Cordis Corporation Company Information
 Table 141. Cordis Corporation Description and Business Overview
 Table 142. Cordis Corporation Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Cordis Corporation Cerebrovascular Intervention Guidewire Product
 Table 144. Cordis Corporation Recent Developments/Updates
 Table 145. Cook Medical Company Information
 Table 146. Cook Medical Description and Business Overview
 Table 147. Cook Medical Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Cook Medical Cerebrovascular Intervention Guidewire Product
 Table 149. Cook Medical Recent Developments/Updates
 Table 150. Lepu Meidcal Company Information
 Table 151. Lepu Meidcal Description and Business Overview
 Table 152. Lepu Meidcal Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Lepu Meidcal Cerebrovascular Intervention Guidewire Product
 Table 154. Lepu Meidcal Recent Developments/Updates
 Table 155. Scientia Vascular Company Information
 Table 156. Scientia Vascular Description and Business Overview
 Table 157. Scientia Vascular Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Scientia Vascular Cerebrovascular Intervention Guidewire Product
 Table 159. Scientia Vascular Recent Developments/Updates
 Table 160. FMD Co., Ltd. Company Information
 Table 161. FMD Co., Ltd. Description and Business Overview
 Table 162. FMD Co., Ltd. Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. FMD Co., Ltd. Cerebrovascular Intervention Guidewire Product
 Table 164. FMD Co., Ltd. Recent Developments/Updates
 Table 165. Sino Medical Sciences Technology Inc. Company Information
 Table 166. Sino Medical Sciences Technology Inc. Description and Business Overview
 Table 167. Sino Medical Sciences Technology Inc. Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Sino Medical Sciences Technology Inc. Cerebrovascular Intervention Guidewire Product
 Table 169. Sino Medical Sciences Technology Inc. Recent Developments/Updates
 Table 170. MicroPort NeuroTech Company Information
 Table 171. MicroPort NeuroTech Description and Business Overview
 Table 172. MicroPort NeuroTech Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 173. MicroPort NeuroTech Cerebrovascular Intervention Guidewire Product
 Table 174. MicroPort NeuroTech Recent Developments/Updates
 Table 175. Shanghai HeartCare Medical Technology Corporation Limited Company Information
 Table 176. Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
 Table 177. Shanghai HeartCare Medical Technology Corporation Limited Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 178. Shanghai HeartCare Medical Technology Corporation Limited Cerebrovascular Intervention Guidewire Product
 Table 179. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
 Table 180. Peijia Medical Company Information
 Table 181. Peijia Medical Description and Business Overview
 Table 182. Peijia Medical Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 183. Peijia Medical Cerebrovascular Intervention Guidewire Product
 Table 184. Peijia Medical Recent Developments/Updates
 Table 185. Zhejiang Medical Devices Co., Ltd. Owned By Year Company Information
 Table 186. Zhejiang Medical Devices Co., Ltd. Owned By Year Description and Business Overview
 Table 187. Zhejiang Medical Devices Co., Ltd. Owned By Year Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 188. Zhejiang Medical Devices Co., Ltd. Owned By Year Cerebrovascular Intervention Guidewire Product
 Table 189. Zhejiang Medical Devices Co., Ltd. Owned By Year Recent Developments/Updates
 Table 190. Shanghai Yingtai Medical Equipment Company Information
 Table 191. Shanghai Yingtai Medical Equipment Description and Business Overview
 Table 192. Shanghai Yingtai Medical Equipment Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 193. Shanghai Yingtai Medical Equipment Cerebrovascular Intervention Guidewire Product
 Table 194. Shanghai Yingtai Medical Equipment Recent Developments/Updates
 Table 195. Beijing Taijieweiye Technology Company Information
 Table 196. Beijing Taijieweiye Technology Description and Business Overview
 Table 197. Beijing Taijieweiye Technology Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 198. Beijing Taijieweiye Technology Cerebrovascular Intervention Guidewire Product
 Table 199. Beijing Taijieweiye Technology Recent Developments/Updates
 Table 200. Shunmei MEDICAL Company Information
 Table 201. Shunmei MEDICAL Description and Business Overview
 Table 202. Shunmei MEDICAL Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 203. Shunmei MEDICAL Cerebrovascular Intervention Guidewire Product
 Table 204. Shunmei MEDICAL Recent Developments/Updates
 Table 205. MicroVenti Company Information
 Table 206. MicroVenti Description and Business Overview
 Table 207. MicroVenti Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 208. MicroVenti Cerebrovascular Intervention Guidewire Product
 Table 209. MicroVenti Recent Developments/Updates
 Table 210. Artiria Medical Company Information
 Table 211. Artiria Medical Description and Business Overview
 Table 212. Artiria Medical Cerebrovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 213. Artiria Medical Cerebrovascular Intervention Guidewire Product
 Table 214. Artiria Medical Recent Developments/Updates
 Table 215. Key Raw Materials Lists
 Table 216. Raw Materials Key Suppliers Lists
 Table 217. Cerebrovascular Intervention Guidewire Distributors List
 Table 218. Cerebrovascular Intervention Guidewire Customers List
 Table 219. Cerebrovascular Intervention Guidewire Market Trends
 Table 220. Cerebrovascular Intervention Guidewire Market Drivers
 Table 221. Cerebrovascular Intervention Guidewire Market Challenges
 Table 222. Cerebrovascular Intervention Guidewire Market Restraints
 Table 223. Research Programs/Design for This Report
 Table 224. Key Data Information from Secondary Sources
 Table 225. Key Data Information from Primary Sources
 Table 226. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cerebrovascular Intervention Guidewire
 Figure 2. Global Cerebrovascular Intervention Guidewire Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Cerebrovascular Intervention Guidewire Market Share by Type: 2025 & 2032
 Figure 4. Stainless Steel Type Product Picture
 Figure 5. Alloy Type Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Cerebrovascular Intervention Guidewire Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Cerebrovascular Intervention Guidewire Market Share by Application: 2025 & 2032
 Figure 9. Hospitals
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Cerebrovascular Intervention Guidewire Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Cerebrovascular Intervention Guidewire Market Size (US$ Million), 2021–2032
 Figure 14. Global Cerebrovascular Intervention Guidewire Sales (K Units), 2021–2032
 Figure 15. Global Cerebrovascular Intervention Guidewire Average Price (US$/Unit), 2021–2032
 Figure 16. Cerebrovascular Intervention Guidewire Report Years Considered
 Figure 17. Cerebrovascular Intervention Guidewire Sales Share by Manufacturers in 2025
 Figure 18. Global Cerebrovascular Intervention Guidewire Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Cerebrovascular Intervention Guidewire Players: Market Share by Revenue in Cerebrovascular Intervention Guidewire in 2025
 Figure 20. Cerebrovascular Intervention Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Cerebrovascular Intervention Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Cerebrovascular Intervention Guidewire Sales Market Share by Country (2021–2032)
 Figure 23. North America Cerebrovascular Intervention Guidewire Revenue Market Share by Country (2021–2032)
 Figure 24. United States Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Cerebrovascular Intervention Guidewire Sales Market Share by Country (2021–2032)
 Figure 27. Europe Cerebrovascular Intervention Guidewire Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Cerebrovascular Intervention Guidewire Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Cerebrovascular Intervention Guidewire Revenue Market Share by Region (2021–2032)
 Figure 35. China Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Cerebrovascular Intervention Guidewire Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Cerebrovascular Intervention Guidewire Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Cerebrovascular Intervention Guidewire Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Cerebrovascular Intervention Guidewire Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Cerebrovascular Intervention Guidewire Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Cerebrovascular Intervention Guidewire by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Cerebrovascular Intervention Guidewire by Type (2021–2032)
 Figure 55. Global Cerebrovascular Intervention Guidewire Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Cerebrovascular Intervention Guidewire by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Cerebrovascular Intervention Guidewire by Application (2021–2032)
 Figure 58. Global Cerebrovascular Intervention Guidewire Price (US$/Unit) by Application (2021–2032)
 Figure 59. Cerebrovascular Intervention Guidewire Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network